Metronomic Chemotherapy in Advanced Gastric Cancer
Status:
Unknown status
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
phase II study of weekly metronomic chemotherapy using weekly Paclitaxel, Oxaliplatin,
Leucovorin and 5-FU (POLF) in patients with advanced gastric cancer